CN103463254A - 一种治疗过敏性鼻炎的中药组合物 - Google Patents
一种治疗过敏性鼻炎的中药组合物 Download PDFInfo
- Publication number
- CN103463254A CN103463254A CN2013103737231A CN201310373723A CN103463254A CN 103463254 A CN103463254 A CN 103463254A CN 2013103737231 A CN2013103737231 A CN 2013103737231A CN 201310373723 A CN201310373723 A CN 201310373723A CN 103463254 A CN103463254 A CN 103463254A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 206010039085 Rhinitis allergic Diseases 0.000 title claims abstract description 28
- 201000010105 allergic rhinitis Diseases 0.000 title claims abstract description 28
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 238000011282 treatment Methods 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 241000931705 Cicada Species 0.000 claims abstract description 3
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 3
- 241000255791 Bombyx Species 0.000 claims description 10
- 241000756943 Codonopsis Species 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 241000545442 Radix Species 0.000 claims description 4
- 241000219780 Pueraria Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 32
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 210000004072 lung Anatomy 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000132011 Atractylodes lancea Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241001233914 Chelidonium majus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000007853 Sarothamnus scoparius Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 206010028748 Nasal obstruction Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000010753 nasal discharge Diseases 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 206010002653 Anosmia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010050515 Hyposmia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000019559 hyposmia Nutrition 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229960004754 astemizole Drugs 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000027993 eye symptom Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960000351 terfenadine Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310373723.1A CN103463254B (zh) | 2013-08-26 | 2013-08-26 | 一种治疗过敏性鼻炎的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310373723.1A CN103463254B (zh) | 2013-08-26 | 2013-08-26 | 一种治疗过敏性鼻炎的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103463254A true CN103463254A (zh) | 2013-12-25 |
CN103463254B CN103463254B (zh) | 2015-03-18 |
Family
ID=49788446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310373723.1A Expired - Fee Related CN103463254B (zh) | 2013-08-26 | 2013-08-26 | 一种治疗过敏性鼻炎的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103463254B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104208483A (zh) * | 2014-09-21 | 2014-12-17 | 王中杰 | 一种治疗过敏性鼻炎的中药组合物 |
CN106075315A (zh) * | 2016-08-19 | 2016-11-09 | 上海世道健康科技有限公司 | 一种抗过敏的中药组合及其制备方法 |
CN106539908A (zh) * | 2015-09-15 | 2017-03-29 | 郭进军 | 一种治疗过敏性鼻炎和皮肤过敏的中药组合物 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105267434A (zh) * | 2015-10-27 | 2016-01-27 | 叶宗耀 | 一种治疗过敏性结膜炎的中药组合物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1080545A (zh) * | 1993-09-29 | 1994-01-12 | 黄晓威 | 药魁搽鼻剂及其制备工艺 |
CN101912526A (zh) * | 2010-08-07 | 2010-12-15 | 王金花 | 一种治疗过敏性鼻炎的药物及其制备方法 |
-
2013
- 2013-08-26 CN CN201310373723.1A patent/CN103463254B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1080545A (zh) * | 1993-09-29 | 1994-01-12 | 黄晓威 | 药魁搽鼻剂及其制备工艺 |
CN101912526A (zh) * | 2010-08-07 | 2010-12-15 | 王金花 | 一种治疗过敏性鼻炎的药物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
周芸: "标本兼治过敏性鼻炎", 《中国中医药报》 * |
曾屹生: "中药治疗变应性鼻炎进展", 《实用中医药杂志》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104208483A (zh) * | 2014-09-21 | 2014-12-17 | 王中杰 | 一种治疗过敏性鼻炎的中药组合物 |
CN106539908A (zh) * | 2015-09-15 | 2017-03-29 | 郭进军 | 一种治疗过敏性鼻炎和皮肤过敏的中药组合物 |
CN106075315A (zh) * | 2016-08-19 | 2016-11-09 | 上海世道健康科技有限公司 | 一种抗过敏的中药组合及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103463254B (zh) | 2015-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103356756B (zh) | 一种治疗过敏性鼻炎的中药组合物 | |
CN103211892B (zh) | 一种治疗失眠的中药组合物 | |
CN103463404B (zh) | 一种治疗肝肾阴虚的中药组合物 | |
CN103386008B (zh) | 一种治疗内分泌失调的中药组合物 | |
CN103705866A (zh) | 一种治疗月经过少的中药组合物 | |
CN104042814A (zh) | 一种治疗过敏性鼻炎的中药组合物 | |
CN102988672B (zh) | 一种治疗月经不调的中药组合物 | |
CN103784887A (zh) | 一种治疗肾虚腰痛的中药组合物 | |
CN103223118B (zh) | 一种治疗面瘫的中药组合物 | |
CN103463254B (zh) | 一种治疗过敏性鼻炎的中药组合物 | |
CN101129496A (zh) | 治疗顽固性头痛的中药 | |
CN104043087A (zh) | 一种治疗雷诺氏综合症的中药组合物 | |
CN103272143A (zh) | 一种治疗痤疮的中药组合物 | |
CN103393860B (zh) | 一种治疗肝阳上亢的中药组合物 | |
CN103550531A (zh) | 一种治疗肾气不足症的中药组合物 | |
CN103721082B (zh) | 一种治疗肩周炎的中药组合物 | |
CN104758529A (zh) | 一种治疗风寒感冒的中药组合物 | |
CN103705659A (zh) | 一种治疗鼻炎的中药组合物 | |
CN102988804A (zh) | 一种治疗风热感冒的中药组合物 | |
CN105963635A (zh) | 一种治疗头痛的中药组合物 | |
CN102698073B (zh) | 一种治疗过敏性鼻炎的中药浸膏 | |
CN105079515A (zh) | 一种治疗外伤后头痛的中药组合物 | |
CN104758528A (zh) | 一种治疗头痛的中药组合物 | |
CN103735829A (zh) | 一种治疗自汗的中药组合物 | |
CN104173934A (zh) | 一种治疗坐骨神经痛的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LI YAN Free format text: FORMER OWNER: RONGCHENG RESEARCH INSTITUTE OF SCIENTIFIC + TECHNICAL INFORMATION Effective date: 20150211 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Yan Inventor after: Tang Weicheng Inventor after: Sun Shengbo Inventor before: Sun Shengbo |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN SHENGBO TO: LI YAN TANG WEICHENG SUN SHENGBO Free format text: CORRECT: ADDRESS; FROM: 264300 WEIHAI, SHANDONG PROVINCE TO: 264200 WEIHAI, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150211 Address after: 264200 Guangming Road, Huancui District, Shandong, Weihai, China, 51 Applicant after: Li Yan Address before: 264300 Rongcheng City, Shandong Province Cultural East Road, No. 20, No. Applicant before: Rongcheng Research Institute of Scientific & Technical Information |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150318 Termination date: 20150826 |
|
EXPY | Termination of patent right or utility model |